E | F | G | H | I | J | L | M | N | O | P | Q | U | V | AC | AD | AE | AG | AH | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Clinical case ID (CIDp) | Primary diagnosis | Year of collection (YYYY) | Material type | Collection media | Sample collection method | Preservation/ Fixation | Biospecimen type | Processing type | Volume | Measurement units | Aliquots | CASPAR score | Date of diagnosis | Patient Age | Patient Gender | Patient Race | Therapy history | Treatment details | |
54 | CIDp780022631 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 2006 | 59 | F | Caucasian (White) | Treated | Ehlafra 20 mg\day since 20-Feb-2015, Ketonal 200 mg\day since 16-Feb-2016 | |
60 | CIDp780030592 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 2005 | 39 | F | Caucasian (White) | Treated | Methotrexate 10 mg\week since 2009, Airtal 100 mg\day since Mar-2016 | |
61 | CIDp780030594 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 2014 | 58 | F | Caucasian (White) | Treated | Methotrexate 10 mg\day since Mar-2014, Movalis 15 mg\day since Mar-2016 | |
62 | CIDp780030595 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | 2009 | 67 | M | Caucasian (White) | Treated | Methotrexate 15 mg\day since 2014, Arcoxia 90 mg\day since Oct-2015 | |
63 | CIDp780030600 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | 2011 | 34 | F | Caucasian (White) | Treated | Meloxicam 15 mg\day since 14-Jan-2016, Methotrexate 60 mg\6 months since May-2015 | |
64 | CIDp780030602 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | 2014 | 34 | M | Caucasian (White) | Treated | Methotrexate 60 mg\6months since 2015, Meloxicam 15 mg since 201 | |
65 | CIDp780030615 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 2010 | 50 | M | Caucasian (White) | Treated | Methotrexate 20 mg\week from 2010 till now, Meloxicam 15 mg\day since 2015 | |
66 | CIDp780030630 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 2010 | 55 | F | Caucasian (White) | Treated | Methotrexate 10 mg\week since 2013, Airtal 0.1 g since 2013 | |
68 | CIDp780030631 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 2006 | 69 | F | Caucasian (White) | Treated | Ehlafra 20 mg\day since 20-Feb-2015, Ketonal 200 mg\day since 16-Feb-2016, Methotrexate 10 mg\week from 2011 to Feb-2015 | |
69 | CIDp780030632 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | 2006 | 69 | F | Caucasian (White) | Treated | Ehlafra 20 mg\day since 20-Feb-2015, Ketonal 200 mg\day since 16-Feb-2016, Methotrexate 10 mg\week from 2011 to Feb-2015 | |
70 | CIDp780030633 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 5 | 2014 | 58 | F | Caucasian (White) | Treated | Methotrexate 10 mg\week , Amelotex 15 mg\day since 19-Feb to 26-Feb-2016 | |
71 | CIDp780030634 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | 1981 | 55 | F | Caucasian (White) | Treated | Methotrexate 10 mg\week since 2013, Airtal 0.1 since 2013 | |
72 | CIDp780030635 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | 1999 | 43 | M | Caucasian (White) | Treated | Movalis 15mg since 2014, Methotrexate 5 mg\week since Jun-2014 | |
73 | CIDp780030636 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | Apr-2013 | 61 | F | Caucasian (White) | Treated | Methotrexate 10 mg\week since 2013, Movalis 15 mg\day since 2013 | |
74 | CIDp780030637 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | Oct-2015 | 78 | F | Caucasian (White) | Treated | Methotrexate 10 mg\week since Sep-2015, Airtal 200 mg\day since 2013 | |
75 | CIDp780030638 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 2006 | 42 | F | Caucasian (White) | Treated | Methotrexate 15 mg\week, Airtal 200 mg\day | |
76 | CIDp780030640 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 5 | 2013 | 59 | F | Caucasian (White) | Treated | Methotrexate 10 mg /week from Oct-2013 to Nov-2014, Leflunomide 20 mg\day from Nov-2015 to Nov-2015,Arioxia 90 mg\day since 2013, Movalis 90 mg\day since 2013 | |
77 | CIDp780030641 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 4 | 1995 | 63 | F | Caucasian (White) | Treated | Methotrexate 10 mg /week Since 1996 , Sulfasalazin 2g/ day from 1995 to 1996, Asathioprine 10 mg/ day from Oct-2007 to Nov-2007, Prednisolone 10 – 5 mg since 2014, Cyclosporin 100 mg/day from 2013 to 2014, Arava 20 mg/day from 2013 to Jan-2016 | |
78 | CIDp780030642 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | Unknown | 59 | F | Caucasian (White) | Treated | Humira (Adalimumab), Metoject | |
79 | CIDp780030643 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 5 | Unknown | 55 | M | Caucasian (White) | Treated | Sulfasalazin, Methotrexate, Humira | |
80 | CIDp780030644 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 5 | Unknown | 26 | M | Caucasian (White) | Treated | Methotrexate, Folic acid, Ketonal DUO | |
81 | CIDp780030645 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 5 | Unknown | 46 | M | Caucasian (White) | Treated | Methotrexate, Humira | |
82 | CIDp780030646 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 5 | Unknown | 50 | F | Caucasian (White) | Treated | Methotrexate, Folic acid, Airtal | |
83 | CIDp780030647 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | Unknown | 48 | F | Caucasian (White) | Treated | Metoject 10 mg since 2013, Remicade 300 mg since 2013 | |
84 | CIDp780030648 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | Unknown | 33 | F | Caucasian (White) | Treated | Metoject 10 mg since Feb-2015, Adelimumab 40 mg since Feb-2014 | |
85 | CIDp780030649 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | Unknown | 56 | M | Caucasian (White) | Treated | Metoject 15 mg Since Jun-2014, Adelimumab 40 mg since 2015 | |
86 | CIDp780030654 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | 1986 | 52 | M | Caucasian (White) | Treated | Infliximab 400 mg since Mar-2012; Metoject 15 mg/week since Mar-2012 | |
87 | CIDp780030655 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | 2005 | 61 | F | Caucasian (White) | Treated | Golimumab 50 mg once a month since 2012; Metoject 10 mg/week | |
88 | CIDp780030656 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 5 | 2008 | 56 | F | Caucasian (White) | Treated | Infliximab 500 mg since Oct-2014; Methotrexate 15 mg since Oct-2014 | |
89 | CIDp780030657 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 4 | Apr-2013 | 59 | M | Caucasian (White) | Treated | Methotrexate 10 mg/week since Apr-2013, 15 mg/week since Feb-2016; Folic acid 5 g/week since Apr-2013, Nimesil 100-200 g/day since Apr-2013 | |
90 | CIDp780030658 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 4 | Apr-2015 | 50 | F | Caucasian (White) | Treated | Methotrexate 10 mg/week since Feb-2015, 20 mg/week since Sep-2016; Folic acid 5-7 g/week since Apr-2015; Prednisolone 10-2.5 mg/day since Apr-2015 | |
91 | CIDp780030660 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 2000 | 30 | F | Caucasian (White) | Treated | Metoject 10 mg since Oct-2014; Infliximab 300 mg since 2015 | |
92 | CIDp780030661 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 3 | Dec-2012 | 53 | F | Caucasian (White) | Treated | Sulfasalazine 2 g/day since Dec-2012; Methotrexate 10 mg/day since Dec-2015; Ketonal 200 mg/day since Dec-2012 | |
93 | CIDp780030662 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 1979 | 46 | F | Caucasian (White) | Treated | Infliximab 40 mg transfusions since Dec-2013; Metoject 7.5 mg hypodermic since Mar-2014 | |
94 | CIDp780030663 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 5 | Sep-2010 | 54 | M | Caucasian (White) | Treated | Sulfasalazine 3 g/day 2010-2011; Methotrexate 15 mg/week since Jan-2015; Humira 40 mg hypodermic 2013-2014 | |
95 | CIDp780030664 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 4 | Jan-2015 | 50 | F | Caucasian (White) | Treated | Methotrexate 25 mg/week since Feb-2015 until Jun-2015; Prednisolone 5-10 mg/week since 2015; Enbrel since 20-Nov-2015 until 03-Nov-2016; Arava 20 mg/day Oct-Nov 2015 | |
96 | CIDp780030665 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 2006 | 45 | M | Caucasian (White) | Treated | Infliximab 500 mg since Oct-2011; Methotrexate 12,5 mg since Oct-2011 | |
97 | CIDp780030666 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 5 | 2004 | 32 | M | Caucasian (White) | Treated | Adelimumab 40 mg subcutaneously since Oct-2011; Metoject 15 mg subcutaneously since Oct-2011 | |
98 | CIDp780030667 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 1993 | 27 | M | Caucasian (White) | Treated | Methotrexate 10 mg since Feb-2013; Infliximab 400 mg since Feb-2013 | |
99 | CIDp780030669 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 1998 | 43 | M | Caucasian (White) | Treated | Infliximab 500 mg since Oct-2011; Metoject 15 mg since 2010 | |
100 | CIDp780030670 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | 1982 | 50 | M | Caucasian (White) | Treated | Infliximab 400 mg since Oct-2013; Metoject 7.5 mg since 1998 | |
101 | CIDp780030672 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | Oct-2015 | 78 | F | Caucasian (White) | Treated | Methotrexate 10 mg/week since Sep-2015; Airtal 200 mg/day since Sep-2015 | |
102 | CIDp780030673 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 4 | 2012 | 55 | F | Caucasian (White) | Treated | Methotrexate 5, then 15 mg/week since 2002 (dose increases since 2014); Folic acid 5g/week since 2002; Nise 200 mg/day since 2002, intermittently | |
103 | CIDp780030674 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 5 | 20-Nov-2015 | 64 | M | Caucasian (White) | Treated | Methotrexate 15 mg/week since Oct-2015, then 20 mg/week since Nov-2016; Folic acid 5-10 mg/week since Nov-2015; Airtal 200 mg/day since Nov-2015 | |
104 | CIDp780030675 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 4 | Jan-2015 | 50 | F | Caucasian (White) | Treated | Methotrexate 25 mg/week since Feb-2015 until Jun-2015; Prednisolone 5-10 mg/week since 2015; Enbrel since 20-Nov-2015 until 03-Nov-2016; Arava 20 mg/day Oct-Nov 2015 | |
105 | CIDp780030676 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 4 | 2000 | 52 | F | Caucasian (White) | Treated | Infliximab 400 mg per injection since Apr-2014; Methotrexate 7, then 20, then 15 mg/week since 2000; Folic acid 5-10 g/week since 2000 | |
106 | CIDp780030677 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 6 | 2006 | 58 | F | Caucasian (White) | Treated | Infliximab 300 mg since Oct-2009; Metoject 10 mg since Jan-2007 | |
107 | CIDp780030678 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 5 | 2011 | 54 | F | Caucasian (White) | Treated | Methotrexate 10 mg/week since 01-Dec-2015; Airtal 100 mg twice a day since 01-Dec-2015 | |
108 | CIDp780030679 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 4 | 2000 | 30 | F | Caucasian (White) | Treated | Infleximab, Methotrexate 15 mg/week | |
109 | CIDp780030680 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 4 | 05-Dec-2014 | 37 | M | Caucasian (White) | Treated | Adalimumab (Humira) 40 mg/day since Oct-2015; Methotrexate 15 mg/week since Oct-2015 | |
110 | CIDp780030681 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 5 | 2002 | 56 | F | Caucasian (White) | Treated | Methotrexate 10, then 20 mg/week since 2003; Prednisolone 10 mg/day 2002-2003; Sulfasalazin 2 g/day 2002-2003; Remicade 500 mg per injection 2012-2014; Stelara 90 mg/month since Feb-2015 until Oct-2015 | |
111 | CIDp780030682 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 2 | ml | 2 x 1 ml | 4 | May-2015 | 19 | M | Caucasian (White) | Treated | Nise 200 mg/day since Oct-2015; Methotrexate 10 mg/week since Sep-2015 until Oct-2015; Prednisolone 10, then 5 mg/day since Oct-2015 | |
112 | CIDp780030683 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | 2003 | 47 | F | Caucasian (White) | Treated | Methotrexate 10 mg/day since 2003 until Jan-2016; Movalis 15 mg/day since 2015 | |
113 | CIDp780030744 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 5 | ml | 5 x 1 ml | 6 | 1999 | 49 | F | Caucasian (White) | Treated | Methotrexate 20 mg/week since 2010; Airtal 0,2 since Nov-2015 | |
115 | CIDp780032772 | Psoriatic arthritis | 2016 | Blood | EDTA | Venopunction | Frozen | Plasma | Standard spun | 1 | ml | 1 x 1 ml | 6 | 2007 | 39 | M | Caucasian (White) | Treated | Methotrexate 10 mg\week since 2013-2016, Methotrexate 15 mg\week since Jan-2016, Meloxicam 15 mg\day since Jan-2016 | |
116 | TIDp100000003 | Psoriatic arthritis | 2017 | Blood | K3-EDTA | Venopunction | Frozen | Plasma | Standard spun | 9 | ml | 1 x 9 ml | Unknown | Unknown | 48 | F | Caucasian (White) | Treated | UVB-311nm 3 sessions | |
118 | TIDp100000004 | Psoriatic arthritis | 2017 | Blood | K3-EDTA | Venopunction | Frozen | Plasma | Standard spun | 9 | ml | 1 x 9 ml | Unknown | Unknown | 18 | F | Caucasian (White) | Treated | Methotrexate | |
120 | TIDp100000005 | Psoriatic arthritis | 2017 | Blood | K3-EDTA | Venopunction | Frozen | Plasma | Standard spun | 10 | ml | 1 x 10 ml | Unknown | Unknown | 36 | F | Caucasian (White) | Untreated | N/A |